Q1 2026 earnings call recap: revenue, EPS, ARR, AI innovation, ShareFile integration, churn risks, and 2026 guidance—read now.

INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a late-stage biotechnology company focused on inflammation and immunology, today announces its financial results for the year ended December 31, 2025 ...

How High Will Gold Go This Year? The Strategic Case for $6,000 — And Beyond In a year when political tensions and market nerves are rewriting asset allocation playbooks, one number keeps grabbing the ...

Garrett Motion Inc. remains attractively valued after Q4 2025, with strong revenue growth and disciplined capital allocation.

IN February this year, the then Minister of State for Finance, Dr. Doris Uzoka-Anite, confirmed what government officials had largely sidestepped when she told senators that, truly, the Federal ...

There is no recent news for this security. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your ...

The New Markets Tax Credit (NMTC) is a powerful and adaptable tool for communities seeking to draw private investment to ...

The climate capital reset isn’t coming, it’s suddenly here. Rising energy prices are reshaping the economics of the global ...

Operator: Good afternoon, ladies and gentlemen, and welcome to the Sera Prognostics, Inc. Fourth Quarter 2025 Financial ...

Annual operating expenses -- $36.6 million, holding steady versus $36.7 million in the prior year as spending shifted toward ...

Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Erika Rasure is globally-recognized as a ...

CEO of The Arena Group explains capital allocation balancing growth, debt, and shareholder value. Trump mocks Biden and Obama for how they walk — and it reveals more than he realizes El Niño forecast ...